Low skeletal muscle mass predicts relevant clinical outcomes in head and neck squamous cell carcinoma. A meta analysis.

Published in: Therapeutic advances in medical oncology (2021)

The cumulative prevalence of sarcopenia in HNSCC is 42.0%. Sarcopenia is an independent risk factor for OS and DFS in patients with HNSCC who undergo curative therapy. Sarcopenia is associated with the occurrence of severe postoperative complications.

Keyphrases

skeletal muscle
insulin resistance
risk assessment
risk factors
community dwelling
early onset
adipose tissue
rectal cancer
metabolic syndrome
cell therapy
smoking cessation